Evidence map›Paper›PMID 28929280›Full record

ReviewMycopathologia2018

Ecology of Scedosporium Species: Present Knowledge and Future Research.

A Rougeron, S Giraud, A Alastruey-Izquierdo, J Cano-Lira, J Rainer, A Mouhajir, S Le Gal, G Nevez, W Meyer, J P Bouchara

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mycopathologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Immunoproteomic Identification ofJournal of proteome research · 2025
    Article
  5. Article
  6. Deciphering the phenol degradation metabolic pathway inApplied and environmental microbiology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Clinical characterization of immunocompetent patients withRespiratory medicine case reports · 2025
    Article
  11. Case report: co-infection ofAME case reports · 2025
    Article
  12. First environmental survey ofFrontiers in cellular and infection microbiology · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

A RougeronUniversité de Bordeaux, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France. amandine.rougeron@gmail.com.
S GiraudHost-Pathogen Interaction Study Group, EA, 3142, UNIV Angers, UNIV Brest, Université Bretagne-Loire, Angers, France.
A Alastruey-IzquierdoMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
J Cano-LiraMycology Unit, Medical School/Oenology School, Universitat Rovira i Virgili, Reus, Spain.
J RainerLeopold Franzens University, Innsbruck, Austria.
A MouhajirHost-Pathogen Interaction Study Group, EA, 3142, UNIV Angers, UNIV Brest, Université Bretagne-Loire, Angers, France.
S Le GalHost-Pathogen interaction Study Group, EA 3142, UNIV Angers, UNIV Brest, Université Bretagne-Loire, Brest, France.
G NevezHost-Pathogen interaction Study Group, EA 3142, UNIV Angers, UNIV Brest, Université Bretagne-Loire, Brest, France.
W MeyerMolecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology Sydney Medical School, Western Clinical School, Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Westmead Hospital, Westmead Institute for Medical Research, Westmead, NSW, Australia.
J P BoucharaHost-Pathogen Interaction Study Group, EA, 3142, UNIV Angers, UNIV Brest, Université Bretagne-Loire, Angers, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genus Scedosporium, which comprises at least five clinically relevant species, i.e. Scedosporium apiospermum, Scedosporium boydii, Scedosporium aurantiacum, Scedosporium dehoogii and Scedosporium minutisporum, ranks the second among the filamentous fungi colonizing the airways of patients with cystic fibrosis (CF). This colonization of the airways is thought to contribute to the inflammatory reaction leading to a progressive deterioration of the lung function. Additionally, these colonizing fungi may lead to severe disseminated infections in case of lung transplantation. Therefore, considering the low susceptibility of Scedosporium species to all current antifungal drugs, preventive measures should be defined to reduce the risk of exposure to these fungi for non-colonized CF patients. With this in mind, several studies have been conducted to elucidate the ecology of these fungi and to define possible sources of patient contamination. This review will summarize the major outcomes of those studies, including: the clear demonstration that ecological niches of Scedosporium species are strongly impacted by human activities, and the ability of Scedosporium species to degrade aliphatic and aromatic pollutants which supports the high occurrence of these species in contaminated soils and polluted waters and makes them promising candidates for bioremediation purposes. Finally, prospects for future research in this field are proposed.

Indexed as

Cystic FibrosisEnvironmental ExposureHumansLung Diseases, FungalScedosporiumAliphatic and aromatic hydrocarbonsEcological nichesHuman-impacted areasScedosporium species

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.